Cetaxone

PRESENTATION:

Cetaxone® 500 mg IM injection: Each 500 mg vial contains dry substance equivalent to 500 mg Ceftriaxone (as sterile Ceftriaxone Sodium USP) accompanied by a solvent ampoule of 2 ml Lidocaine HCl USP 1% Injection for IM injection.

Cetaxone® 1 gm IV injection: Each 1 gm vial contains dry substance equivalent to 1 gm Ceftriaxone (as sterile Ceftriaxone Sodium USP) accompanied by a solvent ampoule of 10 ml Water for Injection BP for IV injection.

Cetaxone® 2 gm IV injection: Each 2 gm vial contains dry substance equivalent to 2 gm Ceftriaxone (as sterile Ceftriaxone Sodium USP) and each of 2 ampoules contains 10 ml Water for Injection BP for IV injection.

 

INDICATION:

Cetaxone is indicated for the treatment of the following major infections when caused by
susceptible organisms: Renal and urinary tract infections, Lower respiratory tract infections,
particularly pneumonia, Gonococcal infections, Skin and soft tissue, bone and joint infections,
Bacterial meningitis, Serious bacterial infections e.g. septicemia, ENT infections, Infections in
cancer patients, Prevention of postoperative infection, Perioperative prophylaxis of infections
associated with surgery, Typhoid fever